Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Kevan C Herold

1-50 of 171 results

View this query on the Wikidata Query Service
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

scientific article published on May 2002
Genetics, pathogenesis and clinical interventions in type 1 diabetes

scientific article
A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

scientific article
Control of TH17 cells occurs in the small intestine.

scientific article
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

scientific article
Type 1 diabetes immunotherapy using polyclonal regulatory T cells

scientific article published on November 25, 2015
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

scientific article published in January 2004
Familial hyperinsulinism caused by an activating glucokinase mutation

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

scientific article
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

scientific article published on June 27, 2011
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

scientific article published on 05 April 2013
Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs

scientific article
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs

scientific article published on 15 September 2005
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

scientific article published on October 2015
Type 1 diabetes as a relapsing-remitting disease?

scientific article published on December 2007
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data

scientific article
Detection of β cell death in diabetes using differentially methylated circulating DNA.

scientific article published on 9 November 2011
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders

scientific article published on 08 July 2013
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes

scientific article
A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.

scientific article
Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells.

scientific article
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years

scientific article published on 14 May 2009
How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited

scientific article published on May 2011
Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

scientific article
Reprogramming human T cell function and specificity with non-viral genome targeting

scientific article published in Nature
Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells

scientific article published on 02 August 2007
Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes

scientific article published on 01 December 2006
Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy

scientific article published on April 1, 2015
Natural history of beta-cell function in type 1 diabetes

scientific article
Beta-cell mass and type 1 diabetes: going, going, gone?

scientific article published on November 2008
Insulin secretion in type 1 diabetes

scientific article published in February 2004
Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation

scientific article published on 31 October 2011
Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial

scientific article published on 25 June 2013
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

scientific article published in March 2006
RAGE ligation affects T cell activation and controls T cell differentiation

scientific article published on September 2008
Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice

scientific article
Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress

scientific article published on 18 May 2007
Specific peripheral B cell tolerance defects in patients with multiple sclerosis

scientific article published on 15 May 2013
Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells

scientific article published on 12 December 2013
Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products

scientific article published in July 2004
Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes.

scientific article published on 12 August 2009
β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice

scientific article published on 4 February 2017
β Cell death and dysfunction during type 1 diabetes development in at-risk individuals

scientific article published on February 2, 2015
Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis

scientific article published on April 2008
Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes

article
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

scientific article published on October 21, 2012
Immune Therapy and β-Cell Death in Type 1 Diabetes

scientific article published on February 19, 2013
Effect of rituximab on human in vivo antibody immune responses

scientific article published on September 9, 2011
A carbon nanotube-polymer composite for T-cell therapy

scientific article published on 3 August 2014
Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response.

scientific article published on December 2007

Paulina is supported by:

About Paulina

Help